Incidence and predictors of unplanned non-target lesion revascularisation up to three years after drug-eluting stent implantation: Insights from a pooled analysis of the RESOLUTE Global Clinical Trial Program

2016-07-01

EuroIntervention , Volume 12 - Issue 4 p. 465- 472

Additional Metadata
Keywords	Coronary artery disease, Drug-eluting stent, Risk factors, Zotarolimus-eluting stent
Persistent URL	doi.org/10.4244/EIJY15M07_07, hdl.handle.net/1765/98967
Journal	EuroIntervention
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Abdel-Wahab, M., Neumann, F.-J. (Franz-Joseph), Serruys, P., Silber, S., Leon, M., Mauri, L., … Richard, G. (2016). Incidence and predictors of unplanned non-target lesion revascularisation up to three years after drug-eluting stent implantation: Insights from a pooled analysis of the RESOLUTE Global Clinical Trial Program. EuroIntervention, 12(4), 465–472. doi:10.4244/EIJY15M07_07

Publication